Clearmind Medicine Inc (NASDAQ: CMND) stock jumped 7.36% on Friday to $0.13 against a previous-day closing price of $0.12. With 0.7 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.03 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.1350 whereas the lowest price it dropped to was $0.1176. The 52-week range on CMND shows that it touched its highest point at $6.10 and its lowest point at $0.12 during that stretch. Beta for the stock currently stands at -1.76.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CMND was down-trending over the past week, with a drop of -2.33%, but this was down by -12.53% over a month. Three-month performance dropped to -69.44% while six-month performance fell -78.95%. The stock lost -97.66% in the past year, while it has lost -95.89% so far this year.
Float and Shares Shorts:
At present, 14.64 million CMND shares are outstanding with a float of 12.93 million shares on hand for trading. On Oct 30, 2023, short shares totaled 0.32 million, which was 2.20% higher than short shares on Sep 28, 2023. In addition to Dr. Adi Zuloff-Shani Ph.D. as the firm’s Chief Executive Officer, Mr. Alan Mark Rootenberg B.Com., B.Comm, C.A., CPA serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 3.14% of CMND’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CMND since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Summary of Insider Activity:
Insiders traded CMND stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.
